首页 正文

Cosibelimab: A Novel Therapeutic for Advanced Cutaneous Squamous Cell Carcinoma

{{output}}
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer worldwide. Treatments of locally advanced cSCC (laCSCC) and metastatic cSCC (mCSCC) have been evolving with the introduction of immunotherapies, which target the programmed cell dea... ...